Clinical trials: Pancreatic Beta Cell Function
Type 2 Diabetes
Effect on Beta Cell Function and Glycaemic Control After Insulin and Exenatide Sequential Therapy
Whether GLP-1 receptor agonists sequential therapy in newly diagnosed type 2 diabetic patients can further improve glycemic control, diabetes remission rate and β-cell function after the short-term insulin intensive therapy.
- Trial name
- T2DMRS (NCT02129985)
- Testing
- Exenatide, Metformin
- Where
- China
- Volunteers
- 100 people
- Sponsor
- xiaolong zhao
Type 2 Diabetes Mellitus
An Exploratory Study of DS-8500a on Beta Cell Function Using Hyperglycemic Clamp
The objective of the study is to evaluate change in insulin secretory capacity in patients with type 2 diabetes mellitus as determined by hyperglycemic clamp after a 28-day oral administration of DS-8500a at 75 mg in a…
- Trial name
- NCT02669732
- Testing
- DS-8500a
- Where
- Japan
- Volunteers
- 21 people
- Sponsor
- Daiichi Sankyo Co., Ltd.
Diabetes Mellitus, Type 2, Obesity
Role of Interleukin-6 in Exercise
The purpose of the study is to understand the role of interleukin-6 during physical activity in patients with type 2 diabetes.
- Trial name
- Exil-6 (NCT01073826)
- Testing
- Sport, Tocilizumab, Sitagliptin
- Where
- Switzerland
- Volunteers
- 56 people
- Sponsor
- University of Zurich
Diabetes Mellitus, Type 2
A Clinical Study to Assess the Effect of Vildagliptin on Beta Cell Function in Drug Naive Patients With Type 2 Diabetes
This study is not being conducted in the United States. The purpose of this study is to assess the effect of vildagliptin, an unapproved drug, on various measures of pancreatic islet function in people with type 2 diabetes who…
- Trial name
- NCT00260156
- Testing
- vildagliptin
- Where
- Switzerland
- Volunteers
- 59 people
- Sponsor
- Novartis Pharmaceuticals